2023
DOI: 10.14283/jpad.2023.90
|View full text |Cite
|
Sign up to set email alerts
|

Cognitive Performance and Incident Alzheimer’s Dementia in Men Versus Women

Abstract: Background The utility of neuropsychological measurements as forerunners of Alzheimer’s Disease Dementia (AD) in individuals with normal cognition or mild cognitive impairment (MCI) is undeniable. Objectives To assess the differential prognostic value of cognitive performance in older men versus women. Design Longitudinal analysis of data acquired from the National Alzheimer’s Coordinating Center Uniform Data Set. Settings … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 35 publications
0
4
0
Order By: Relevance
“…Considering the impact of neurodegenerative disorders, it is necessary to develop widely accessible and easily operated tools to overcome early diagnostic challenges [ 93 , 94 , 95 ]. Thanks to its user-friendly nature and compatibility with other functional neuroimaging techniques, fNIRS holds great potential for the diagnostic assessment of early neurocognitive and motor decline.…”
Section: Discussionmentioning
confidence: 99%
“…Considering the impact of neurodegenerative disorders, it is necessary to develop widely accessible and easily operated tools to overcome early diagnostic challenges [ 93 , 94 , 95 ]. Thanks to its user-friendly nature and compatibility with other functional neuroimaging techniques, fNIRS holds great potential for the diagnostic assessment of early neurocognitive and motor decline.…”
Section: Discussionmentioning
confidence: 99%
“…The yearly worldwide cost of dementia is estimated at $1.3 trillion [47]. Thus, accurate and prompt intervention is of utmost importance [48,49].…”
Section: Discussionmentioning
confidence: 99%
“…Hence, clinical manifestations have been long used as preclinical markers of AD and non–AD dementias 6–8 . Alzheimer research has already revealed sex‐specific patterns in the preclinical courses of cognitive and neuropsychiatric manifestations 9,10 . To enhance the utility of NPS as forerunners of LBD, we explored sex‐specific patterns in the preclinical course of LBD.…”
Section: Variable Hazard Ratio Lower 95% Upper 95% P‐value Variable ...mentioning
confidence: 99%
“…[6][7][8] Alzheimer research has already revealed sex-specific patterns in the preclinical courses of cognitive and neuropsychiatric manifestations. 9,10 To enhance the utility of NPS as forerunners of LBD, we explored sex-specific patterns in the preclinical course of LBD. Future research must confirm our findings and examine additional prodromal clinical markers in search of an optimized predictive model that will serve preclinical detection purposes for individuals at high risk of converting to LBD.…”
mentioning
confidence: 99%